<DOC>
	<DOCNO>NCT02365870</DOCNO>
	<brief_summary>This study evaluate effectiveness rotigotine transdermal patch reduce anxiety people Parkinson 's disease .</brief_summary>
	<brief_title>Anxiety Parkinson 's : Use Quantitative Methods Guide Rational Treatment</brief_title>
	<detailed_description>Anxiety serious medical condition worsens quality life negatively affect people thought , feeling , ability function normally . Anxiety affect anyone , people Parkinson 's appear much high risk estimate 40 % suffer anxiety . Parkinson 's neurological disorder cause tremor problem normal movement . The disease symptom believe cause large part loss dopamine produce cell midbrain . Anxiety Parkinson 's may associate loss dopamine cause disease therefore may respond dopamine base treatment . This study evaluate effectiveness rotigotine transdermal patch , dopamine replacement medication , reduce symptom anxiety people Parkinson 's disease . Participants double-blind study randomly assign receive either rotigotine placebo patch 8-weeks . All participant evaluate study site baseline week 2 , 4 , 8 . Psychiatric , cognitive , movement assessment perform along review anxiety symptom . All participant offer continued routine psychiatric care study physician upon completion study .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>N 0437</mesh_term>
	<criteria>Diagnosis DSM 5 Anxiety Disorder Stable medical history general health On stable antiparkinsonian therapy 2 week enrollment Unstable medical disease comorbid psychiatric disease Dementia Subjects less one year duration Parkinson 's Current treatment dopamine agonist</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Anxiety Disorders</keyword>
	<keyword>Parkinson Disease</keyword>
	<keyword>rotigotine</keyword>
</DOC>